Robert A. Kyle, MD: Lessons From a Legend
In this issue of Mayo Clinic Proceedings, there are 2 articles authored by a living legend in medicine: Robert A. Kyle, MD.1,2 The scientific contributions of Dr Kyle over a remarkable 60-year career in medicine have no parallel. From his first publication in 19593 to his latest articles in this issue of the Proceedings, Dr Kyle has defined and redefined the epidemiology, diagnosis, risk stratification, prognosis, and management of the entire spectrum of plasma cell disorders. From monoclonal gammopathy of undetermined significance (MGUS) to multiple myeloma,4-6 his academic legacy is unmatched.
